Product References
Arl4c promotes the growth and drug resistance of pancreatic cancer by regulating tumor-stromal interactions.
iScience
Chen X,Zhang Y,Qian W,Han L,Li W,Duan W,Wu Z,Wang Z,Ma Q
Fri Dec 17 00:00:00 UTC 2021
Arl4c promotes the growth and drug resistance of pancreatic cancer by regulating tumor-stromal interactions.
iScience
Chen X,Zhang Y,Qian W,Han L,Li W,Duan W,Wu Z,Wang Z,Ma Q
Fri Dec 17 00:00:00 UTC 2021
Integrative epigenomic and high-throughput functional enhancer profiling reveals determinants of enhancer heterogeneity in gastric cancer.
Genome medicine
Sheng T,Ho SWT,Ooi WF,Xu C,Xing M,Padmanabhan N,Huang KK,Ma L,Ray M,Guo YA,Sim NL,Anene-Nzelu CG,Chang MM,Razavi-Mohseni M,Beer MA,Foo RSY,Sundar R,Chan YH,Tan ALK,Ong X,Skanderup AJ,White KP,Jha S,Tan P
Mon Oct 11 00:00:00 UTC 2021
CRL5-dependent regulation of the small GTPases ARL4C and ARF6 controls hippocampal morphogenesis.
Proceedings of the National Academy of Sciences of the United States of America
Han JS,Hino K,Li W,Reyes RV,Canales CP,Miltner AM,Haddadi Y,Sun J,Chen CY,La Torre A,Simó S
Tue Sep 15 00:00:00 UTC 2020
CRL5-dependent regulation of the small GTPases ARL4C and ARF6 controls hippocampal morphogenesis.
Proceedings of the National Academy of Sciences of the United States of America
Han JS,Hino K,Li W,Reyes RV,Canales CP,Miltner AM,Haddadi Y,Sun J,Chen CY,La Torre A,Simó S
Tue Sep 15 00:00:00 UTC 2020
A risk stratification model based on four novel biomarkers predicts prognosis for patients with renal cell carcinoma.
World journal of surgical oncology
Kubota S,Yoshida T,Kageyama S,Isono T,Yuasa T,Yonese J,Kushima R,Kawauchi A,Chano T
Thu Oct 22 00:00:00 UTC 2020
ARL4C is associated with initiation and progression of lung adenocarcinoma and represents a therapeutic target.
Cancer science
Kimura K,Matsumoto S,Harada T,Morii E,Nagatomo I,Shintani Y,Kikuchi A
Sun Mar 01 00:00:00 UTC 2020
ARL4C is associated with initiation and progression of lung adenocarcinoma and represents a therapeutic target.
Cancer science
Kimura K,Matsumoto S,Harada T,Morii E,Nagatomo I,Shintani Y,Kikuchi A
Sun Mar 01 00:00:00 UTC 2020
Clinical relevance of ARF/ARL family genes and oncogenic function of ARL4C in endometrial cancer.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Zhang J,Zhang Q,Sun C,Huang Y,Zhang J,Wang Q
Fri May 01 00:00:00 UTC 2020
ADP-ribosylation factor-like 4C is a predictive biomarker of poor prognosis in patients with renal cell carcinoma.
American journal of cancer research
Isono T,Chano T,Yoshida T,Makino A,Ishida S,Suzaki M,Kageyama S,Kawauchi A,Yonese J,Yuasa T
Tue Sep 29 00:00:00 UTC 2020
ADP-ribosylation factor-like 4C predicts worse prognosis in endometriosis-associated ovarian cancers.
Cancer biomarkers : section A of Disease markers
Wakinoue S,Chano T,Amano T,Isono T,Kimura F,Kushima R,Murakami T
Fri Jul 26 00:00:00 UTC 2019
A rapid, reversible, and tunable method to regulate protein function in living cells using synthetic small molecules.
Cell
Banaszynski LA,Chen LC,Maynard-Smith LA,Ooi AG,Wandless TJ
Fri Sep 08 00:00:00 UTC 2006
A rapid, reversible, and tunable method to regulate protein function in living cells using synthetic small molecules.
Cell
Banaszynski LA,Chen LC,Maynard-Smith LA,Ooi AG,Wandless TJ
Fri Sep 08 00:00:00 UTC 2006
A rapid, reversible, and tunable method to regulate protein function in living cells using synthetic small molecules.
Cell
Banaszynski LA,Chen LC,Maynard-Smith LA,Ooi AG,Wandless TJ
Fri Sep 08 00:00:00 UTC 2006